Mitochondrial Transporter ABCB10 Protects Against Doxorubicin‐Induced Respiratory Muscle Dysfunction Independent of Changes to Diaphragm Accumulation
Why the study?
Does ABCB10 overexpression prevent doxorubicin-induced respiratory muscle dysfunction in a rat model?
Population
Female Sprague-Dawley rats modeling doxorubicin-induced respiratory muscle toxicity.
Comparison
Overexpression of ABCB10 via rAAV9-MHCK7-ABCB10… vs Saline vector or saline antisense…
Design
Preclinical
Follow-up
2 days following single doxorubicin dose or 2 days…
Key result
ABCB10 improved diaphragm fatigue (138.2 s vs. 104.6 s), specific force (22.12 N/cm² vs. 18.31 N/cm²), and fibre area in rats treated with doxorubicin, independent of drug accumulation.
Authors
Loading...
Should not change clinical practice; hypothesis-generating for ABCB10 in anthracycline myotoxicity.
Does ABCB10 overexpression prevent doxorubicin-induced respiratory muscle dysfunction in a rat model?
ABCB10 overexpression protects against doxorubicin-induced diaphragm muscle weakness by regulating mitochondrial iron and heme synthesis, independent of doxorubicin accumulation.
Smuder et al. (2026) studied this question. ABCB10 improved diaphragm fatigue (138.2 s vs. 104.6 s), specific force (22.12 N/cm² vs. 18.31 N/cm²), and fibre area in rats treated with doxorubicin, independent of drug accumulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: